BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 38680780)

  • 1. C-Reactive protein and the kynurenic acid to quinolinic acid ratio are independently associated with white matter integrity in major depressive disorder.
    Zheng H; Teague TK; Yeh FC; Burrows K; Figueroa-Hall LK; Aupperle RL; Khalsa SS; Paulus MP; Savitz J
    Brain Behav Immun; 2022 Oct; 105():180-189. PubMed ID: 35853557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine 5-Hydroxyindoleacetic Acid Negatively Correlates with Migraine Occurrence and Characteristics in the Interictal Phase of Episodic Migraine.
    Fila M; Chojnacki J; Derwich M; Chojnacki C; Pawlowska E; Blasiak J
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower serum insulin-like growth factor 2 level in patients with bipolar disorder is associated with the severity of manic symptoms during manic episodes.
    Ye SY; Zhao Y; Liu ZB; Luo CP; Xiong JW; Zhan JQ; Li YH; Wei B; Chen CN; Yang YJ
    Front Psychiatry; 2024; 15():1354999. PubMed ID: 38563028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the effect of prolonged fasting on kynurenine pathway metabolites and stress markers in healthy male individuals.
    Louvrou V; Solianik R; Brazaitis M; Erhardt S
    Eur J Clin Nutr; 2024 May; ():. PubMed ID: 38789718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Metabolic Factor Kynurenic Acid of Kynurenine Pathway Predicts Major Depressive Disorder.
    Liu H; Ding L; Zhang H; Mellor D; Wu H; Zhao D; Wu C; Lin Z; Yuan J; Peng D
    Front Psychiatry; 2018; 9():552. PubMed ID: 30510519
    [No Abstract]   [Full Text] [Related]  

  • 6. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
    Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
    Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
    Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kynurenine pathway in major depressive disorder under different disease states: A systematic review and meta-analysis.
    Ou W; Chen Y; Ju Y; Ma M; Qin Y; Bi Y; Liao M; Liu B; Liu J; Zhang Y; Li L
    J Affect Disord; 2023 Oct; 339():624-632. PubMed ID: 37467793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kynurenine pathway changes in late-life depression.
    Wu Y; Zhong X; Mai N; Wen Y; Shang D; Hu L; Chen B; Zhang M; Ning Y
    J Affect Disord; 2018 Aug; 235():76-81. PubMed ID: 29655078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum neuroactive metabolites of the tryptophan pathway in patients with acute phase of affective disorders.
    Li Y; Wang L; Huang J; Zhang P; Zhou Y; Tong J; Chen W; Gou M; Tian B; Li W; Luo X; Tian L; Hong LE; Li CR; Tan Y
    Front Psychiatry; 2024; 15():1357293. PubMed ID: 38680780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of immune activation on the kynurenine pathway and depression symptoms - A systematic review and meta-analysis.
    Hunt C; Macedo E Cordeiro T; Suchting R; de Dios C; Cuellar Leal VA; Soares JC; Dantzer R; Teixeira AL; Selvaraj S
    Neurosci Biobehav Rev; 2020 Nov; 118():514-523. PubMed ID: 32853625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Tryptophan Catabolite or Kynurenine Pathway in a Major Depressive Episode with Melancholia, Psychotic Features and Suicidal Behaviors: A Systematic Review and Meta-Analysis.
    Almulla AF; Thipakorn Y; Vasupanrajit A; Tunvirachaisakul C; Oxenkrug G; Al-Hakeim HK; Maes M
    Cells; 2022 Oct; 11(19):. PubMed ID: 36231075
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.